 BRYAN, Texas, Jan. 05, 2023 GLOBE NEWSWIRE iBio, Inc. NYSEA:IBIO iBio or the Company, an AI-driven innovator of precision antibody immunotherapies, today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 11,545,238, entitled Machine Learning Method For Protein Modelling To Design Engineered Peptides, which covers a machine learning model ...... 